Xtx Topco LTD Ultragenyx Pharmaceutical Inc. Transaction History
Xtx Topco LTD
- $1.12 Billion
- Q2 2024
A detailed history of Xtx Topco LTD transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 7,495 shares of RARE stock, worth $407,952. This represents 0.03% of its overall portfolio holdings.
Number of Shares
7,495
Previous 13,221
43.31%
Holding current value
$407,952
Previous $617,000
50.08%
% of portfolio
0.03%
Previous 0.09%
Shares
7 transactions
Others Institutions Holding RARE
# of Institutions
287Shares Held
88.1MCall Options Held
505KPut Options Held
198K-
Vanguard Group Inc Valley Forge, PA9.78MShares$532 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$305 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.35MShares$291 Million0.68% of portfolio
-
Wellington Management Group LLP Boston, MA4.56MShares$248 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$177 Million2.24% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.81B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...